Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin dependent kinase 19 (CDK19) is a serine/threonine protein kinase and a member of the cyclin-dependent kinase family, specifically within the CDK8 subfamily. It functions as part of a four-protein Mediator kinase module that associates with the larger Mediator complex, which regulates RNA Polymerase II-mediated gene expression. It is involved in transcriptional regulation, cell cycle control, and immune responses. Dysregulation is linked to developmental disorders and cancer.
Inhibition of CDK19 kinase activity to modulate transcription and cell cycle progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin Dependent Kinase 19 (None).